News Quantified

EVOK – evoke pharma, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Evoke Pharma, Inc. (NASDAQ: EVOK) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Evoke Pharma, Inc. (NASDAQ: EVOK) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications

Evoke Pharma, Inc. (NASDAQ: EVOK) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Evoke Pharma, Inc. (NASDAQ: EVOK) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Form ARS Evoke Pharma Inc For: Dec 31

Form DEFA14A Evoke Pharma Inc

Form DEF 14A Evoke Pharma Inc For: Apr 10

Form PRE 14A Evoke Pharma Inc For: Mar 29

Form 424B3 Evoke Pharma Inc

Top News Gainers

4/14 Form DEF 14A Evoke Pharma Inc For: May 27 11.6%

6/27 Evoke Pharma Requests Type A FDA Meeting to Plan for Resubmission of Gimoti™ NDA 6.0%

10/16 Evoke Pharma Inc (NASDAQ: EVOK) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $1.00 price target on the stock. 5.8%

12/4 Evoke Pharma Inc (NASDAQ: EVOK) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $1.75 price target on the stock. 3.9%

5/28 Evoke Pharma Inc (NASDAQ: EVOK) had its "hold" rating re-affirmed by analysts at HC Wainwright. 3.6%

3/3 Form 4 Evoke Pharma Inc For: Feb 28 Filed by: Gonyer David A 2.9%

5/7 Evoke Pharma Inc (NASDAQ: EVOK) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 2.9%

9/17 Evoke Pharma Completes Manufacturing of Commercial Scale Registration Batches of Gimoti™ 2.1%

6/19 Form 4 Evoke Pharma Inc For: Jun 17 Filed by: Gonyer David A 2.0%

11/13 Evoke Pharma Granted 180-Day Extension by Nasdaq Regarding Minimum Bid Price 1.1%

Top News Decliners

1/21 Form 8-K Evoke Pharma Inc For: Jan 21 -30.0%

8/8 Form 8-K Evoke Pharma Inc For: Aug 08 -15.6%

11/18 Evoke Pharma up 32% [Seeking Alpha] -11.3%

12/20 Form 8-K Evoke Pharma Inc For: Dec 20 -10.7%

3/12 Evoke Pharma Reports Fourth Quarter and Full Year 2019 Financial Results -9.9%

5/8 Form 10-Q Evoke Pharma Inc For: Mar 31 -9.4%

3/26 Evoke Pharma Inc (NASDAQ: EVOK) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -7.5%

7/10 Evoke Pharma Inc (NASDAQ: EVOK) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -6.0%

1/23 Evoke Pharma Enters Commercialization Agreement with EVERSANA Life Sciences for Gimoti™ -4.3%

12/2 Evoke Pharma Regains Compliance with Nasdaq Minimum Bid Requirement -4.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day